A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Refer a Patient Bookmark and Share

Physician Referral

When you refer your patient to City of Hope, you can do so with the utmost confidence that our staff will provide the best care possible for your patient.
 
As a National Cancer Institute-designated comprehensive cancer center, City of Hope is a recognized leader in innovative discoveries and novel treatments that revolutionize the fields of cancer research as well as cancer prevention, detection and care. This means your patient will be treated in accordance to the most up-to-date, evidence-based guidelines and have access to promising new therapies.
 
How to Refer a Patient
 
You or your office may refer a patient through any of the below options:
 
  • Call 800-826-HOPE (4673) Monday through Friday 8 a.m. to 5 p.m. to speak with a patient referral specialist. After hours calls will be answered within one business day.
  • Fax a referral request letter with a patient face sheet to 626-301-8432.
  • Complete the online referral request form.
 
We will work with your patient to complete the registration process and to schedule an appointment at the patient's convenience.
 
You will be notified once the appointment is scheduled and we will continue to work with you and your office to coordinate care during and after the patient’s treatment at City of Hope.
 
Additional Resources:
 
 
For You, the Health Professional:
 
  • Continuing Medical Education (CME) - City of Hope has a long-standing commitment to CME, sharing advances in cancer research and treatment with the health-care community through conferences, symposia, grand rounds, e-learning modules and other CME opportunities for medical professionals.
  • Physician Relations - City of Hope's Physician Relations team strives to continually address and assess the needs of our physician partners and their staff. For more information, contact physician relations at 800-826-HOPE(4673).
  • PHYSICIANews - PHYSICIANews provides medical professionals with news and information about advances in cancer prevention, treatment, research, clinical trials and upcoming continuing medical education (CME) programs.
 

Refer a Patient

Physician Referral

When you refer your patient to City of Hope, you can do so with the utmost confidence that our staff will provide the best care possible for your patient.
 
As a National Cancer Institute-designated comprehensive cancer center, City of Hope is a recognized leader in innovative discoveries and novel treatments that revolutionize the fields of cancer research as well as cancer prevention, detection and care. This means your patient will be treated in accordance to the most up-to-date, evidence-based guidelines and have access to promising new therapies.
 
How to Refer a Patient
 
You or your office may refer a patient through any of the below options:
 
  • Call 800-826-HOPE (4673) Monday through Friday 8 a.m. to 5 p.m. to speak with a patient referral specialist. After hours calls will be answered within one business day.
  • Fax a referral request letter with a patient face sheet to 626-301-8432.
  • Complete the online referral request form.
 
We will work with your patient to complete the registration process and to schedule an appointment at the patient's convenience.
 
You will be notified once the appointment is scheduled and we will continue to work with you and your office to coordinate care during and after the patient’s treatment at City of Hope.
 
Additional Resources:
 
 
For You, the Health Professional:
 
  • Continuing Medical Education (CME) - City of Hope has a long-standing commitment to CME, sharing advances in cancer research and treatment with the health-care community through conferences, symposia, grand rounds, e-learning modules and other CME opportunities for medical professionals.
  • Physician Relations - City of Hope's Physician Relations team strives to continually address and assess the needs of our physician partners and their staff. For more information, contact physician relations at 800-826-HOPE(4673).
  • PHYSICIANews - PHYSICIANews provides medical professionals with news and information about advances in cancer prevention, treatment, research, clinical trials and upcoming continuing medical education (CME) programs.
 
Quick Links
Progress of Cancer Research
PHYSICIANews provides medical professionals with news and information about advances in cancer prevention, treatment, research, clinical trials and upcoming continuing medical education (CME) programs.
 
Patient Care Overview
City of Hope sees patients at all points in their care, from diagnosis, to treatment, through survivorship.
CME Local Events and Conferences


NEWS & UPDATES
  • Urinary tract stones are hard masses, or calculi, that form in the urinary tract and may cause pain, bleeding or an infection, or even block of the flow of urine. Urinary tract stones begin to form in a kidney and may enlarge in a ureter or the bladder. Depending on where a stone is located, […]
  • Every summer, hospitals nationwide experience a shortage of blood donations. This summer is no exception. Nearly 1.7 million new cancer cases are expected to be diagnosed in the U.S. this year,  and many of those patients will need blood transfusions during their treatment. Patients at City of Hope alone rely o...
  • Non-Hodgkin lymphoma facts: Non-Hodgkin lymphoma is a cancer that starts in cells called lymphocytes, which are part of the body’s immune system. Lymphocytes are in the lymph nodes and other lymphoid tissues (such as the spleen and bone marrow). Non-Hodgkin lymphoma is one of the most common cancers in the U.S....
  • Few clinical cancer trials include older adults – and yet, more than 60 percent of cancer cases in the United States occur in people age 65 and older. The result is a dearth of knowledge on how to treat the very population most likely to be diagnosed with cancer. Now, the American Society of Clinical […]
  • Scientists at City of Hope and UCLA have become the first to inhibit the expression of a protein, called TWIST that promotes tumor invasion and metastasis when activated by cancer cells. As such, they’ve taken the first step in developing a potential new therapy for some of the deadliest cancers, including ovar...
  • Upon completing her final round of chemotherapy for ovarian cancer earlier this month, Maria Velazquez-McIntyre, a 51-year-old Antelope Valley resident, celebrated the milestone by giving other patients a symbol of hope – a Survivor Bell. The bell may look ordinary, but for cancer patients undergoing chemothera...
  • Many Americans understand that obesity is tied to heart disease and diabetes but, according to a new survey, too few – only 7 percent – know that obesity increases the risk of cancer. Specific biological characteristics can increase cancer risk in obese people, and multiple studies have shown correlations betwe...
  • As breast cancer survivors know, the disease’s impact lingers in ways both big and small long after treatment has ended. A new study suggests that weight gain – and a possible corresponding increase in heart disease and diabetes risk – may be part of that impact. In the first study to evaluate weight chan...
  • Becoming what’s known as an independent scientific researcher is no small task, especially when working to translate research into meaningful health outcomes. Yet that independent status is vital, enabling researchers to lead studies and avenues of inquiry that they believe to be promising. Clinicians, especial...
  • 720 days. That’s how long Alex Tung, 38, had to give up surfing after being diagnosed with acute myeloid leukemia. For most people, even some surfers, such a hiatus wouldn’t be a big deal, but for Tung, surfing has been everything. The Southern California resident began surfing when he was in elemen...
  • There are few among us who have not experienced loss of a friend or loved one, often without warning, or like those of us who care for people with cancer, after a lingering illness. It is a time when emotions run high and deep, and as time passes from the moment of loss, we often […]
  • For the past four years, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., has been studying how breast cancer cells spread, or metastasize, to the brain, where they become life-threatening tumors. Known as secondary brain tumors, these cancers have become increasingly common as treatment advances have ena...
  • Cutaneous T cell lymphomas are types of non-Hodgkin lymphoma that arise when infection-fighting white blood cells in the lymphatic system – called lymphocytes – become malignant and affect the skin. A primary symptom is a rash that arises initially in areas of the skin that are not normally exposed to sunlight....
  • There’s science camp, and then there’s “mystery” science camp. City of Hope’s new science camp for middle school students is of the especially engaging latter variety. From Monday, July 13, to Friday, July 17, rising middle-school students from across the San Gabriel Valley were presented with a “patient” with ...
  • Women diagnosed with breast cancer quickly learn their tumor’s type, meaning the characteristics that fuel its growth. That label guides the treatment of their disease, as well as their prognosis when it comes to treatment effectiveness. Sometimes, however, doctors can’t accurately predict treatment effectivene...